Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd has informed BSE that its Board of Directors will meet on Friday, January 30, 2026, at the registered office in Vadodara. The agenda is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. Any other business may be taken up with the Chair's permission. The trading window for designated persons has been closed since January 1, 2026, and will reopen 48 hours after the results are declared.
This is a routine pre-results intimation with no new operational or financial information. Shareholders should watch for the actual Q3 FY26 numbers on or after January 30, 2026, which could drive short-term stock movement depending on performance versus expectations.